A University at Buffalo psychiatrist who has played a critical role in getting mental health screening and treatment integrated into routine care for adults and adolescents with cystic fibrosis (CF) has been awarded $3 million from the Cystic Fibrosis Foundation to focus on the mental health of children with the disease.
Cellectis starts alemtuzumab revival with FDA orphan drug win in leukaemia – Pharmaceutical Technology
Alemtuzumab is being tested in a Phase I trial along with Cellectis’ CAR T-cell therapy UCART22. Image credit: Shutterstock / Nemes Laszlo. The US Food
August 2, 2024